NewsSwiss Joint Venture Initiates First Medical Cannabis Import 

Swiss Joint Venture Initiates First Medical Cannabis Import 

-

ASTRASANA Holding AG is an internationally active company focusing on the cultivation, processing and distribution of cannabis products. In addition to its headquarters in Switzerland, Astrasana also has subsidiaries in the Czech Republic, Germany and Japan.

The latest strategic partnership with the medical technology and pharmaceutical specialist Solumedics AG opens up new market perspectives with regard to the use of medical cannabis products in Switzerland and Europe. For the first time, the import of medical cannabis will be possible. 

The Swiss legislation underwent an update on August 01, 2022. According to this, medical cannabis is available after a doctor’s prescription and does not require any further special authorisation from the Federal Office of Public Health. The import and export of corresponding products was also approved and standardised under the supervision of Swissmedic. 

The two partners are pioneers in ensuring the availability of high-quality medical cannabis as an import in Swiss pharmacies, hospitals and care facilities. In pharmacies, the topic of medical cannabis is an area that requires intensive consultation. Astrasana offers well-founded informative material in this specialist area, support in dealing with prescriptions, active ingredients and products, as well as the ordering process. The company can rely on the expertise of a medical doctor and a pharmacist. 

Solumedics CEO Reno Löffler, Owner and Pharmacist Ivan Mihajlovic, Astrasana CEO Yves Antoniazzi

Until now, however, the holding company and its subsidiaries lacked the necessary authorisation to distribute the products regulated by the authorities. This is where Solumedics stepped in. The long-standing pharmaceutical company with a focus on drugs and medical products, applied for the necessary license. While looking for partners in the supply chain of high-quality raw materials and processed cannabis products, they quickly came across Astrasana. 

According to Yves Antoniazzi, CEO of Astrasana Holding, these are the conditions for a match made in heaven: “We are talking about a win-win situation. The liberalization of the cannabis market creates conditions for committed companies that have done the necessary groundwork.

Now two companies are coming together that have joint control over all steps from cultivation of the plants to patient care. From our side, in addition to our own customer network, we are primarily contributing extensive know-how in order to offer high-quality raw materials from sustainable production. Solumedics, in turn, supports us with the narcotics license to enable the import of medical cannabis for the first time.” 

Solumedics AG is also delighted with the collaboration. Reno Löffler, the CEO, knows about the importance of quality and reliability especially in the pharmaceutical business. Cannabis products cannot be obtained from just any grower – only a constant concentration of active ingredients and plant quality allows reproducible processing procedures.

He explained that these play a central role in the approval of medical products: “Pharmacists and doctors must be able to rely on the fact that there are no fluctuations in the efficacy and tolerability of the medicines. That’s why we were looking for a partner who imports GMP-certified pharmaceutical raw materials. Together with Astrasana, we can now serve this market.

Latest news

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Seizure Of 32 Tons Of Cannabis In Spain Was Actually Hemp

BETWEEN telephone calls, Francisco Carbó continues finalising contracts for E-Canna, the hemp processing company he owns based in Valencia,...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing...

You might also likeRELATED
Recommended to you